MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-? Market Disrupter, at BioFuture 2023
Stock Information for Eton Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.